| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |